Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells.

Nature | Aug 3, 2000

http://www.ncbi.nlm.nih.gov/pubmed/10952313

GATA-1 is a tissue-specific transcription factor that is essential for the production of red blood cells. Here we show that overexpression of GATA-1 in erythroid cells inhibits their differentiation, leading to a lethal anaemia. Using chromosome-X-inactivation of a GATA-1 transgene and chimaeric animals, we show that this defect is intrinsic to erythroid cells, but nevertheless cell nonautonomous. Usually, cell nonautonomy is thought to reflect aberrant gene function in cells other than those that exhibit the phenotype. On the basis of our data, we propose an alternative mechanism in which a signal originating from wild-type erythroid cells restores normal differentiation to cells overexpressing GATA-1 in vivo. The existence of such a signalling mechanism indicates that previous interpretations of cell-nonautonomous defects may be erroneous in some cases and may in fact assign gene function to incorrect cell types.

Pubmed ID: 10952313 RIS Download

Mesh terms: Anemia | Animals | Animals, Genetically Modified | Apoptosis | Chimera | Crosses, Genetic | DNA-Binding Proteins | Dosage Compensation, Genetic | Erythroblasts | Erythroid Precursor Cells | Erythroid-Specific DNA-Binding Factors | Erythropoiesis | Female | GATA1 Transcription Factor | Male | Mice | Mice, Inbred C57BL | Signal Transduction | Transcription Factors | X Chromosome

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.